Resmed (RMD) Non-Current Deferred Tax Liability (2010 - 2026)

Resmed (RMD) has reported Non-Current Deferred Tax Liability for 17 consecutive years, with $64.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Deferred Tax Liability fell 16.79% year-over-year to $64.6 million; the trailing twelve-month figure through Jun 2026 stood at $64.6 million (down 16.79% YoY), and the FY2026 full-year result was $64.6 million, down 16.79% from the prior year.
• Non-Current Deferred Tax Liability eased to $64.6 million in Q2 2026 per RMD's latest filing, from $77.9 million in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $113.0 million in Q1 2023 and bottomed at $9.7 million in Q2 2022.
• Historically, Non-Current Deferred Tax Liability has averaged $72.3 million across 5 years, with a median of $78.5 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Non-Current Deferred Tax Liability surged 955.13% in 2023, then declined 23.4% in 2024.
• Over 5 years, Non-Current Deferred Tax Liability stood at $107.5 million in 2022, then retreated by 16.98% to $89.3 million in 2023, then retreated by 13.75% to $77.0 million in 2024, then advanced by 1.29% to $78.0 million in 2025, then decreased by 17.12% to $64.6 million in 2026.
• According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $64.6 million, $77.9 million, and $78.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.